RCEL On The Move, FTSV Acquired, NCNA On Watch, FDA Nod For SNY, COVID-19 Update

Today's Daily Dose brings you news about an update on AVITA's RECELL System, Gilead's acquisition of Forty Seven, Karyopharm's multiple myeloma's trial results, and FDA approval of Sanofi's Sarclisa.

from RTT - Biotech https://ift.tt/2wmorBB
via IFTTT